SCHEMBL26047408

SCHEMBL26047408

CCc1nc(CNC(=O)c2cc3c(nc2OC)nc(C(c2ccccc2)c2ccccc2)n3CC)no1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACSS2 Q9NR19 6/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ APOBEC3A P31941 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAPT P10636 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GRK2 P25098 1/20 0.32
▸ GRK5 P34947 1/20 0.32
▸ GRK1 Q15835 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26047404 0.87 ACSS2 (0.47) ACSS2THRBMAPK1KMT2A
SCHEMBL25366610 0.83 ACSS2 (0.65) ACSS2KDM4EHSD17B10ALOX15APOBEC3A
SCHEMBL26047413 0.80 ACSS2 (0.54) ACSS2KDM4EALOX15L3MBTL1MAPT
SCHEMBL26047384 0.79 ACSS2 (0.70) ACSS2MAPTTHRBMAPK1MEN1
SCHEMBL26047387 0.76 ACSS2 (0.71) ACSS2MAPTMAPK1MEN1KMT2A
SCHEMBL26046870 0.75 ACSS2 (0.46) ACSS2KDM4E
SCHEMBL26047508 0.75 ACSS2 (0.47) ACSS2MAPK1ALDH1A1
SCHEMBL26047373 0.74 ACSS2 (0.46) ACSS2MAPK1IRAK4
SCHEMBL26047502 0.74 ACSS2 (0.46) ACSS2MAPK1
SCHEMBL26046859 0.74 ACSS2 (0.64) ACSS2ALOX15MAPTMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271956-A1 AMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271956-A1 AMIDE DERIVATIVES BRCA1, HRAS, PCNA ACSS2 201/4885KDM4E 2654/4885HSD17B10 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback